Chenjie Zhou

机构：Shanghai Medical College of Fudan University, Wenzhou Medical University, Fudan University Shanghai Cancer Center, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Shanghai Cancer Institute · ORCID：0000-0002-8774-6846

发表论文 45 篇 · 总被引 376 次 · h-index 11

代表论文

• Cancer immunometabolism: advent, challenges, and perspective (2024 · Molecular Cancer · 被引 46)
• YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer (2024 · Cancer Letters · 被引 27)
• Comprehensive Analysis of E3 Ubiquitin Ligases Reveals Ring Finger Protein 223 as a Novel Oncogene Activated by KLF4 in Pancreatic Cancer (2021 · Frontiers in Cell and Developmental Biology · 被引 20)
• PSMD14 Stabilizes SLC7A11 to Ameliorate Glucocorticoid‐Induced Osteoporosis by Suppressing Osteocyte Ferroptosis (2025 · Advanced Science · 被引 19)
• MEN1 Deficiency‐Driven Activation of the β‐Catenin‐MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance (2024 · Advanced Science · 被引 16)
• Transcription factor EB reprograms branched‐chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1 (2024 · Cell Proliferation · 被引 14)